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Background: The fetal consequences of CMV infection have made it one of the most serious infections contracted
during pregnancy. Despite the posed teratogenic risk during pregnancy, there is no national screening test for CMV
infection is available during pregnancy in Kenya. Thus little is known on its epidemiological data that is necessary
for health planners and care providers.
Methods: A cross sectional study was conducted at Thika district level 5 hospital, Kenya to investigate
seroprevalence of CMV infections and associated possible risk factors among pregnant women. Structured
questionnaires were used to gather socio-demographic data and ELISA was used to detect CMV infections using
IgG and IgM.
Results: Out of 260 pregnant women, 201 (77.3%) were CMV IgG 21(8.1%) CMV IgM being on acute stage of the
disease. Marital status (OR = 3.7533, 95% CI =3.0231-6.9631, P < 0.0001), parity (OR = 3.7533, 95% CI = 3.0231-6.9631,
P < 0.0001), and education (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), history of blood transfusion (OR = 0.0374,
95% CI = 0.00120-0.1168, OR = 0.3804) were found to significantly influence seropostivity in univariate analysis.
Conclusion: The 88.4% CMV prevalence rate being detected among pregnant women calls for vaccine and routine
screening for CMV infections and its associated risk factors in this kind of settings.Background
Cytomegalovirus (CMV) is the commonest among viral
infections during perinatal period that cause congenital
CMV infections [1]. Its clinical manifestations range
from asymptomatic forms (90% of cases) to severe fetal
damage that may include permanent hearing, vision
loss, neurological impairment and, in rare cases, death
due to abortion [2-4]. Previous studies have confirmed
that CMV infection is relatively common among women
of reproductive age with seroprevalence ranging from 45%
to 100%. African continent like South America and Asia
has one of the highest prevalence of CMV [4]. From the
previous studies conducted in Africa, CMV prevalence
rates in Egypt were found to be 96% [5], 85.7% Tanzania
[6], 97.2% Benin [7] and 86.4% South Africa [8].
CMV is transmitted from person-to-person via close
non-sexual contact, sexual activity, breastfeeding, blood
transfusions, and organ transplantation [9]. For pregnant* Correspondence: akibera2000@gmail.com
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article, unless otherwise stated.women, important sources of infection include sexual
activity and contact with the urine or saliva of young
children, especially their own children [10]. However,
seroprevalence varies greatly with a variety of epidemio-
logical factors such as geographical distribution, socio-
economic status, marital status and parity [11].
Like other herpes viruses, primary infection is followed
with established of lifelong latent infection from which
periodic reaction is common [12]. At this stage, symptoms
are usually absent including during reaction [13].
As far as prevention is concerned, in addition to health
education campaigns, the serological screening of pregnant
women has been proposed. However, there is no consen-
sus in the scientific community concerning the implemen-
tation of screening and it is not recommended by any
public health system despite its teratogenic effects because
of its cost/benefit ratio [14]. However, other countries
Israel, Belgium, and France their doctors do test their
pregnant patients an intervention to CMV infections
that should be adopted by all [14].
There is no published data concerning CMV sero-
prevalence in pregnant women in Kenya. The basic datad Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ant for health planners and care providers. This study was
therefore aimed at determining the seroprevalence, associ-
ated possible risk factors for CMV infections among preg-
nant women in Thika Kiambu County.
Methods
To determine the seroprevalence of CMV among the ex-
pectant mothers, seeking health services at Thika level 5
hospitals. Consenting pregnant women were approached
to participate in the study. A questionnaire was adminis-
tered and socio-demographic data and blood samples
were collected from 260 consenting participants during
the period of Sept 2012 to April 2013. The participants
were women aged between (18) eighteen years and (45)
forty five years old. The participants were sampled from
the antenatal clinic. A 5ml blood specimen was obtained
for each subject for the evaluation of CMV serum im-
munoglobulin G antibody using a commercial enzyme-
linked immunosorbent assay (Wampole; Inverness Medical
Professional Diagnostics) in accordance with the manufac-
turer’s instructions.
Quantitative analysis for CMV (IgG and IgM) was per-
formed, and the assay result interpreted as IU/mL. The
manufacturer’s instructions were followed for the cut off
points, which was <9 IU/mL for CMV IgG and IgM. In
cases where samples were tested positive for both IgG
and IgM, they further evaluated for the avidity of IgG
antibodies. From the analysis, samples that were found
to have an avidity index >35% were 43(79.63%) while
those detected with <35% were 11(20.37%) indicated
IgG, IgM predominance respectively, Table 1.
Statistics
Univariate and multivariate Odd ratio analysis was con-
ducted and on CMV seropostivity for IgG and IgM and
its association between IgG, IgM seropostivity and, high
parity >4 deliveries, marital status, history of blood trans-
fusion, HIV status, illiteracy, occupation, and residing




A total of 260 pregnant women of the age group of 18–
45 years and in their first or second trimesters wereTable 1 Avidity index among participants with both IgM
and IgG antibodies
Avidity index Participants(n) %
<35% 11 20.37
>35% 43 79.63
Total 54 100.0enrolled into this study. The mean age of the partici-
pants was 28years with most of the responds being
married 168(64.61%) with those divorced being the
least 27(10.39%). More than third (39.4%) of these
women were literate and either in business 68(26.2%)
or employed 70(26.9%). One hundred and thirty seven
137 (53.08%) of the respondents had 1–4 children with
most of the participants residing in urban centres 149
(57.3%), Table 2.
CMV seroprevalence
Out of a total of 260 pregnant women under this study,
201(77.3%) and 21(8%) had seropositive CMV IgG and
IgM, respectively (Table 2). Those on the age group be-
tween 31–35 year old (54), had the highest IgG sero-
positive rates IgG 46 (85.19%) while those under age
21–25 years old 52 had the least 7(22.26%). However
those who were HIV positive (27), had 23(85.2%) IgG
seropositive, Table 2.
Risk factors for CMV infections
Multivariate and univariate analysis was used for CMV IgG
and IgM seropositive groups as dependent variable and
socio-demographic variables as independent variables.
P value <0.05 was considered significant. We therefore
determined if age, high parity >4 deliveries, marital status,
history of blood transfusion, HIV status, illiteracy, occupa-
tion, and residing location had any significance risk to
predict CMV infections. However, marital status, high
parity, history of blood transfusion and age were signifi-
cant risk factors for CMV infection. Geographical location
and occupation and HIV status were not significantly
associated with CMV infection, Table 2.
Discussion
This is the first published data on the epidemiology of
CMV infections among pregnant women in Kenya. Equally
few studies have been conducted among pregnant women
with most studies being among blood donors. However, in
this study, seroprevalence of CMV IgG 77.3% and IgM
8.1% were detected. These findings were similar to those
obtained in Sudan (77.2%) [15]. Contrary to previous stud-
ies conducted in Africa, higher rates have been reported,
in Benin (97.2%) [7], Egypt (96%) [16], Gambia (87%) [17],
South Africa (86.4%) [18], Nigeria (100%), [19], 87% [17]
Dares Salaam, Tanzania [6] and also in South East Asia
[20]. However, in some of European countries, low CMV
infection rates have been reported, Australia (56.9%)
and France (46.8%) [21]. The low prevalence rates could
be due to the inclusion of CMV screening among the
antenatal profile tests and better hygienic standards
[22]. The low prevalence rates of CMV in this study
compared to the rest of the studies in African countries,
could be due to diverse HIV infections (which is an
Table 2 Socio-demographic characteristics and associated factors with CMV infection of pregnant women in Thika,
Kenya
Variable Participants (n/%) IgM (n/%) IgG (n/%) Univariate Multivariate
Age group:
21-25 52(20) 31(12) 7(22.26)
26-30 95(36) 5(13.68) 77(81.05) OR = 0.0898 3.3866
31-35 54(21) 2(3.7) 46(85.19) 95% CI = 0.0017-4.4637 0.0665-172.5
36-40 18(7) 4(22.22) 10(55.56) P = 0.2310 0.5430
41-45 10(4) 1(10) 9(90)
Subtotal 260 21(8.1) 201(77.1)
Marital status:
Single 66(24.39) 9(13.6) 38(57.6) OR = 3.7533 0.3897
Married 168(64.61) 12(7.2) 137(82) 95% CI =3.0231-6.9631 0.004-0.0451
Divorced 27(10.39) 0(0) 26(96.3) P < 0.0001 0.0004
Sub total 260 21 201
Parity:
None 117(45) 12(10.35) 76(65.5) OR = 0.2373 0.2224
One to four 138(53.08) 8(5.8) 121(87.7) 95% CI =0.1246-0.4519 0.1143-0.5643
>four 5(13.59) 0(0) 4(66.7) P < 0.0001 P = 0.0003
Sub total 260 20 240
Trimester of pregnancy:
First 131(50.4) 9(6.9) 101(77.1) OR = 1.881 2.3346
Second 129(49.6) 12(9.3) 100(77.5) 95% CI = 0.4448-2.6617 0.8996-3217
Sub total 260 21 201 P = 0.8532 0.7756
Location:
rural 111(42.7) 9(8.1) 84(75.7) OR = 0.8509 1.0074
urban 149(57.3) 12(8.1) 117(78.5) 95% CI = 0.4746-1.5256 0.489-2.484
Sub total 260 21 201 P = 0.5878 0.9873
Education:
None 3(1.2) 0(0) 3(100) OR = 0.6364 0.427
Primary 12(4.6) 4(33.33) 8(66.7) 95% CI = 0.0318-12.7301 0.0132-13820
Secondary 79(330.4) 9(11.4) 58(73.4) P = 0.7675 0.1001
Tertiary 166(63.8) 8(4.8) 132(79.5)
Sub total 260 21 201
Occupation:
Business 68(26.2) 5(7.4) 55(80.9)
Employed 70(26.9) 3(4.3) 58(82.9) OR 0.6369 1.6143
Housewife 33(12.7) 5(15.2) 26(78.8) 95% CI = 0.2210-1.8359 0.2047-12.7299
Farmer 43(16.5) 3(7.0) 34(79.1) P = 0.04036 0.6494
Student 46(17.7) 5(10.9) 28(60.9)
Sub-total 260 21 201
History of blood transfusion:
No 243(93.5) 20(8.2) 20(8.2) OR = 0.0374 2.7125
Yes 17(6.5) 1(5.9) 12(70.6) 95% CI = 0.00120-0.1168 0.0132-0.01382
Sub Total 260 21 32 P < 0.001 P < 0.003
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Table 2 Socio-demographic characteristics and associated factors with CMV infection of pregnant women in Thika,
Kenya (Continued)
HIV status:
positive 27(10.3) 1(3.7) 23(85.2) OR = 0.3804 1.7767
negative 233(89.6) 20(8.6) 178(76.4) 95% CI = −0.0491-2.9448 0.5890-5.3589
Sub total 260 21 201 P = 0.3546 0.3076
Abbreviations: OR Odds Ratio, CI confidence interval.
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demographics, diverse cultures, population behaviour,
child cares, breast feeding and sexual activity [24]. The
detected 77.3% of CMV infections showed that these
women were at high risk of CMV infections.
From this study, we determined the risk factors that
could influence HIV infections to CMV infections. From
the analysis, women who were married, aged or with
high parity, were found to be at higher risk for CMV in-
fection (Table 2). These risk factors were similar to those
found by previous studies [15]. These factors increased
susceptibility to acquisition of CMV infection, perhaps
through the direct contact with contagious secretions
from their own children or poor hygiene practiced by
these women [25,26]. In addition, in these settings, most
women are usually married based on the customs of most
African settings with high number of children.
There is a lot of debate concerning maternal age and
CMV infection; however most studies including this study
have shown elderly women to be at higher risk of CMV
infection [27], while others reporting contrary [7,18,27].
However, other factors like geographical location, educa-
tion and occupation are not significantly associated with
CMV infection.
CMV IgG avidity assay seems to be one of the most
accessible tools to differentiate between primary from
non-primary CMV infection [28]. This technique is
less expensive and it could be used to confirming CMV
primary infections without the use of sophiscated poly-
merase chain reactions. In our study, high CMV IgG
avidity were confirmed implying that in these women,
their pregnancy could be maintained with a lower risk
of transmitting CMV infections to their offspring (Table 1)
[29]. However, this study was limited with failure to
confirm CMV infections by Polymerase Chain Reaction
(PCR) including failure to make a follow up of IgM ser-
opostivity women to ascertain their infection status/
seroconversion.
Conclusion
This study shows the prevalence of 77.3% similarly to
those obtain from other countries with those married
aged and with high parity being at a high risk to CMV
infections. This study concurs with previous studies thathave suggested all women of the child bearing age to be
incorporated in routine antenatal screening profile.
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